These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24459786)

  • 21. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 22. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thoughts on the improvement of the quality of the drugs prepared in the pharmacy].
    Hädicke M
    Pharm Prax; 1966 Apr; 4():103-4. PubMed ID: 6001079
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dossier of prescription preparations].
    Vanhalle G; Hanquin PJ
    J Pharm Belg; 1996; 51(5):237-84. PubMed ID: 9011601
    [No Abstract]   [Full Text] [Related]  

  • 25. Microbial Identification in Pharmaceutical Compounding.
    Hyde T; Anstead J; Schade L; Zellner J
    Int J Pharm Compd; 2016; 20(1):13-8. PubMed ID: 27125052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Let us improve the work of military pharmacies].
    Tiurin VG
    Voen Med Zh; 1987 Mar; (3):14-7. PubMed ID: 3590637
    [No Abstract]   [Full Text] [Related]  

  • 28. Implementing United States Pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, Part 1.
    Allen LV
    Int J Pharm Compd; 2012; 16(2):146-9. PubMed ID: 23050327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
    Yoch D
    Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 32. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is quality of medicines?
    Doogue MP; Thynne TR
    Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 35. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
    Noorian S; Vahedi N
    Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compounding facilities assessment and planning: A focus on USP <797> and USP <800>.
    Clark JS; Tharp JC; Patel D; Desmarais A
    Am J Health Syst Pharm; 2020 Oct; 77(22):1910-1913. PubMed ID: 32839816
    [No Abstract]   [Full Text] [Related]  

  • 37. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traditional vs. nontraditional pharmacy.
    Allen LV
    Int J Pharm Compd; 2013; 17(4):351. PubMed ID: 24261152
    [No Abstract]   [Full Text] [Related]  

  • 40. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
    Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.